Janssen Czech Republic

Last updated: 17.02.2020


Janssen, the pharmaceutical company of Johnson & Johnson, focuses on some of the most devastating diseases and the most complex medical challenges of our time, across the following five therapeutic areas: Cardiovascular and Metabolism, Neuroscience, Immunology, Oncology and hematology, and Infectious Diseases and Vaccines.

The company currently employs 40,000 employees across 5 continents. R&D investment reaches approximately $ 4.5 billion annually. The company is among the Top 10 companies in terms of sales size.

In 1959, the Swiss company CILAG AG became part of Johnson & Johnson. CILAG AG has been represented in the Czech Republic since 1990. Janssen Pharmaceutica NV itself started its operations three years later. Janssen-Cilag was established in the Czech Republic in 1995 by the merger of two companies – Janssen Pharmaceutica (a division of Imeco ČR and Cilag TIO). The company joined the pharmaceutical sector Johnson & Johnson spol. sro

Since 2005 Janssen-Cilag sro has been operating on the Czech market as a separate legal unit. The company is based in Prague and has 54 employees.



Walterovo náměstí 329/1
158 00 Prague
Czech Republic

Tel: +420 227 012 227




We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here